Compare ADXN & AMSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADXN | AMSS |
|---|---|---|
| Founded | 2002 | 2016 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1M | 4.2M |
| IPO Year | 2019 | 2026 |
| Metric | ADXN | AMSS |
|---|---|---|
| Price | $3.40 | $0.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 773.2K | 70.9K |
| Earning Date | 11-23-2026 | 12-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $767.75 | $3.71 |
| Revenue Next Year | N/A | $20.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.56 | $0.20 |
| 52 Week High | $10.43 | $2.44 |
| Indicator | ADXN | AMSS |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 33.60 |
| Support Level | $2.77 | $0.20 |
| Resistance Level | $3.52 | $0.39 |
| Average True Range (ATR) | 0.46 | 0.04 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 19.11 | 6.38 |
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.